Elevance Health, Inc.
ELV
$428.79
$1.920.45%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 151.53B | 146.22B | 145.11B | 143.50B | 144.59B |
| Total Other Revenue | 31.59B | 30.59B | 28.90B | 28.22B | 27.16B |
| Total Revenue | 183.12B | 176.81B | 174.02B | 171.72B | 171.75B |
| Cost of Revenue | 132.33B | 127.57B | 125.40B | 123.06B | 124.09B |
| Gross Profit | 50.79B | 49.24B | 48.61B | 48.66B | 47.66B |
| SG&A Expenses | 41.04B | 39.47B | 37.38B | 37.41B | 36.67B |
| Depreciation & Amortization | 619.00M | 580.00M | 617.00M | 707.00M | 766.00M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 173.99B | 167.61B | 163.40B | 161.17B | 161.52B |
| Operating Income | 9.13B | 9.20B | 10.61B | 10.55B | 10.22B |
| Income Before Tax | 7.76B | 7.90B | 8.30B | 8.58B | 8.04B |
| Income Tax Expenses | 1.86B | 1.93B | 1.91B | 1.90B | 1.80B |
| Earnings from Continuing Operations | 5.91K | 5.97K | 6.39K | 6.68K | 6.24K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 11.00M | 9.00M | 29.00M | 10.00M | 8.00M |
| Net Income | 5.92B | 5.98B | 6.42B | 6.69B | 6.24B |
| EBIT | 9.13B | 9.20B | 10.61B | 10.55B | 10.22B |
| EBITDA | 10.57B | 10.59B | 12.03B | 12.06B | 11.84B |
| EPS Basic | 25.74 | 25.75 | 27.57 | 28.67 | 26.59 |
| Normalized Basic EPS | 21.44 | 21.61 | 25.63 | 25.41 | 24.45 |
| EPS Diluted | 25.63 | 25.61 | 27.43 | 28.52 | 26.46 |
| Normalized Diluted EPS | 21.35 | 21.49 | 25.51 | 25.30 | 24.35 |
| Average Basic Shares Outstanding | 921.49M | 927.79M | 932.49M | 935.89M | 940.45M |
| Average Diluted Shares Outstanding | 924.80M | 931.80M | 936.50M | 939.90M | 944.30M |
| Dividend Per Share | 6.60 | 6.52 | 6.37 | 6.22 | 6.07 |
| Payout Ratio | 25.60% | 25.22% | 23.08% | 21.69% | 22.79% |